Pure Global AI
ANVISA registration 80134860259Valid until Dec 13, 2028

IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN

ANVISA Registration Number: 80134860259GRIFOLS BRASIL LTDADIAGNOSTIC GRIFOLS, S.A.Risk Class IV
Device names
Technical name
IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN
PT: IMUNOHEMATOLOGIA - ABO - ORIGEM MONOCLONAL
Commercial name
DG Gel ABO/Rh (2D)(RT)
Risk class
Class IV
Registration details
Registration Number
80134860259
Process Number
25351390072201816
CNPJ
02513899000171
Company information
Registration Holder
GRIFOLS BRASIL LTDA
Manufacturing Country
Spain
PT: ESPANHA
Dates and status
Publication Date
Dec 17, 2018
Validity
13/12/2028
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80134860259 and manufactured by DIAGNOSTIC GRIFOLS, S.A.. The registration is held by GRIFOLS BRASIL LTDA with validity until Dec 13, 2028.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.